Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE is a chemical compound with a unique molecular structure that exhibits significant biological activity. It is characterized by the presence of a methyl group at the 6th position and a pyrazoloquinoline core, which contributes to its potential therapeutic properties.

462067-00-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 462067-00-1 Structure
  • Basic information

    1. Product Name: 6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE
    2. Synonyms: AKOS BB-6962;6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE
    3. CAS NO:462067-00-1
    4. Molecular Formula: C11H10N4
    5. Molecular Weight: 198.22
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 462067-00-1.mol
  • Chemical Properties

    1. Melting Point: 279-281 °C(Solv: water (7732-18-5))
    2. Boiling Point: 364.2±52.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.47±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 6.21±0.20(Predicted)
    10. CAS DataBase Reference: 6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE(462067-00-1)
    12. EPA Substance Registry System: 6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE(462067-00-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 462067-00-1(Hazardous Substances Data)

462067-00-1 Usage

Uses

Used in Oncology:
6-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-3-YLAMINE is used as an anticancer agent for the treatment of colon cancer. It effectively inhibits the growth of colon cancer cells through the induction of apoptosis and sub G1 cell cycle arrest, thereby preventing the proliferation and spread of cancerous cells.

Check Digit Verification of cas no

The CAS Registry Mumber 462067-00-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,2,0,6 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 462067-00:
(8*4)+(7*6)+(6*2)+(5*0)+(4*6)+(3*7)+(2*0)+(1*0)=131
131 % 10 = 1
So 462067-00-1 is a valid CAS Registry Number.

462067-00-1Downstream Products

462067-00-1Relevant articles and documents

The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis andin silicomechanistic studies as dual DNA gyrase and DHFR inhibitors

Abulkhair, Hamada S.,Ahmed, Hany E. A.,Al-Karmalamy, Ahmed A.,Alswah, Mohamed,Bayoumi, Ashraf H.,El-Adl, Khaled,El-Gamal, Kamal M.,El-Shershaby, Mohamed H.

, p. 13986 - 14004 (2021/08/16)

The resistance of pathogenic microbes to currently available antimicrobial agents has been considered a global alarming concern. Hence, close attention should be paid to the development of novel potent antimicrobials. Herein, we report the synthesis,in vitroantimicrobial evaluation, of two novel sets of quinoline derivatives as potential DNA gyrase and DHFR inhibitors. The design of new compounds depended on modifying the structural aspects of previously reported fluoroquinolones. In both sets, the methyl group replaced the fluorine atom at C-6. In the first set, the diverse heterocyclic fragments of reported antimicrobial potentials, including pyrazole, isoxazole, and pyrimidine, were attached to C-3 of the quinoline scaffold. In the second set, the quinolone ring was replaced with the pyrazolo[3,4-b]quinoline scaffold to examine the effect of this action on the antimicrobial activity and thein silicovirtual binding with DNA gyrase and DHFR. The preliminary antimicrobial activity of new compounds was assessed against a panel of pathogenic microbes including Gram-positive bacteria (Streptococcus pneumoniaandBacillus subtilis), Gram-negative bacteria (Pseudomonas aeruginosaandEscherichia coli), and fungal strains (Aspergillus fumigatus,Syncephalastrum racemosum, andGeotriucum candidum). Six derivatives displayed relatively potent antimicrobial activity with a percent activity range of 80-113% relative to ampicillin, gentamicin, and amphotericin B as reference antimicrobial agents. Molecular docking studies were conducted to predict the binding affinities of new compounds toward the active sites of DNA gyrase and DHFR as proposed therapeutic targets.

lH-Pyrazolo[3,4-b]quinolin-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrest

Karthikeyan, Chandrabose,Amawi, Haneen,Viana, Arabela Guedes,Sanglard, Leticia,Hussein, Noor,Saddler, Maria,Ashby, Charles R.,Moorthy, N.S. Hari Narayana,Trivedi, Piyush,Tiwari, Amit K.

, p. 2244 - 2249 (2018/05/31)

A series of lH-pyrazolo[3,4-b]quinolin-3-amine derivatives were synthesized and evaluated for anticancer efficacy in a panel of ten cancer cell lines, including breast (MDAMB-231 and MCF-7), colon (HCT-116, HCT-15, HT-29 and LOVO), prostate (DU-145 and PC3), brain (LN-229), ovarian (A2780), and human embryonic kidney (HEK293) cells, a non-cancerous cell line. Among the eight derivatives screened, compound QTZ05 had the most potent and selective antitumor efficacy in the four colon cancer cell lines, with IC50 values ranging from 2.3 to 10.2 μM. Furthermore, QTZ05 inhibited colony formation in HCT-116 cells in a concentration-dependent manner. Cell cycle analysis data indicated that QTZ05 caused an arrest in the sub G1 cell cycle in HCT-116 cells. QTZ05 induced apoptosis in HCT-116 cells in a concentration-dependent manner that was characterized by chromatin condensation and increase in the fluorescence of fluorochrome-conjugated Annexin V. The findings from our study suggest that QTZ05 may be a valuable prototype for the development of chemotherapeutics targeting apoptotic pathways in colorectal cancer cells.

Pyrazolo-fused quinoline analogues: Synthesis of 1H-pyrazolo [3, 4-b] quinolines and 3-amino-1H-pyrazolo [3, 4-b] quinolines from 3-formyl and 3-cyano-2-chloroquinolines

Srivastava, Ambika,Singh, Mrityunjay K.,Singh

, p. 292 - 296 (2007/10/03)

Stepwise synthesis of 1H-pyrazolo [3, 4-b] quinolines 6 has been described from the reactions of 2-chloro-3-formylquinolines 1 with ethyleneglycol and hydrazine hydrate reagents in sequence followed by hydrolysis with BiCl 3. However, 3-amino-1H-pyrazolo[3, 4-b]quinolines 7 have been synthesized from 2-chloro-3-cyanoquinolines 2 with excess of hydrazine hydrate in one step. The functional group manipulation of amino group in compounds 7 has also been studied.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 462067-00-1